Literature DB >> 2119492

Lung-phase immunity to Schistosoma mansoni: definition of alveolar macrophage phenotypes after vaccination and challenge of mice.

E N Menson1, R A Wilson.   

Abstract

Phenotypic changes in murine alveolar macrophages have been described in response to vaccination with irradiated cercariae and to a subsequent challenge with normal parasites. Flow cytometric analysis was used to quantify the proportions of cells strongly positive for a number of macrophage surface markers, detected by a panel of monoclonal primary antibodies and fluorescent secondary antibodies. The proportion of Ia+ macrophages sampled by bronchoalveolar lavage increased 5-fold over days 14 to 28 post-vaccination. This upregulation of Ia was accompanied by a sharp decrease in F4/80 expression between days 14 and 21. The low percentage of F4/80+ cells persisted for several weeks after vaccination, and no further change was stimulated by challenge parasites. These altered characteristics are consistent with the 'activation phenotype' induced by other infectious agents. After challenge of immune mice, further changes in macrophage phenotype were slight compared to the responses elicited by vaccination, or to those induced in the challenge control group; Ia expression increased to about three times normal levels. The phenotypic changes correspond both in magnitude and timing with the pattern of alveolar macrophage activation determined in a previous study. The limited changes in phenotype of alveolar macrophages from immunized mice after challenge could indicate that these cells become refractory to reactivation. Overall, the altered macrophage phenotype after vaccination and challenge provides circumstantial evidence for the action of cytokines, particularly interferon-gamma, in lung-phase immunity to schistosomes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119492     DOI: 10.1111/j.1365-3024.1990.tb00974.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  6 in total

1.  Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages.

Authors:  Ilia N Buhtoiarov; Paul M Sondel; Jon M Wigginton; Tatiana N Buhtoiarova; Eric M Yanke; David A Mahvi; Alexander L Rakhmilevich
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  Dynamics of lung macrophage activation in response to helminth infection.

Authors:  Mark C Siracusa; Joshua J Reece; Joseph F Urban; Alan L Scott
Journal:  J Leukoc Biol       Date:  2008-08-21       Impact factor: 4.962

3.  The lung is an important site for priming CD4 T-cell-mediated protective immunity against gastrointestinal helminth parasites.

Authors:  Marina Harvie; Mali Camberis; Shiau-Choot Tang; Brett Delahunt; William Paul; Graham Le Gros
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

4.  The surface phenotypic characterization of lung macrophages in C3H/HeJ mice.

Authors:  N Bilyk; P G Holt
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

5.  The generation of interferon-gamma-producing T lymphocytes in skin-draining lymph nodes, and their recruitment to the lungs, is associated with protective immunity to Schistosoma mansoni.

Authors:  A P Mountford; P S Coulson; R M Pemberton; L E Smythies; R A Wilson
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

Review 6.  Role of nitric oxide in parasitic infections.

Authors:  S L James
Journal:  Microbiol Rev       Date:  1995-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.